We develop financing solutions that support the growth of our corporate clients and generate value for their investors.

Transactions

Below is a list of transactions Chardan has closed to date. To view the associated press releases, visit the Press Release section.
View by
Icon Grid
Icon List

NeuroVive Pharmaceutical AB

$8.5 Million

Public Offering

May, 2015

Sole Placement Agent

REGENXBIO Inc.

$70.5 Million

Private Placement

May, 2015

Sole Placement Agent

StemCells, Inc.

$25 Million

Public Offering

April, 2015

Co-Manager

GW Pharmaceuticals plc

$179.2 Million

Public Offering

April, 2015

Selling Group

Check-Cap

$24 Million

IPO

February, 2015

Lead Underwriter

Golar LNG

$214 Million

Secondary Offering

January, 2015

Selling Group

ORBCOMM, Inc.

$72 Million

Public Offering

November, 2014

Co-Manager

Rockwell Medical

$58.5 Million

Public Offering

November, 2014

Co-Manager

On Track Innovations

$10 Million

Public Offering

November, 2014

Selling Group

Nanosphere, Inc.

$20 Million

Public Offering

October, 2014

Underwriter

Fifth Street Asset Management

$102 Million

IPO

October, 2014

Selling Group

DT Asia Investments Ltd

$60 Million

IPO

October, 2014

Selling Group